This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Asrir, A. et al. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell https://doi.org/10.1016/j.ccell.2022.01.002 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harjes, U. Points of entry for tumour-infiltrating lymphocytes. Nat Rev Cancer 22, 194 (2022). https://doi.org/10.1038/s41568-022-00460-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-022-00460-7